182 related articles for article (PubMed ID: 27389277)
1. Clinical significance of mitofusin-2 and its signaling pathways in hepatocellular carcinoma.
Wu Y; Zhou D; Xu X; Zhao X; Huang P; Zhou X; Song W; Guo H; Wang W; Zheng S
World J Surg Oncol; 2016 Jul; 14(1):179. PubMed ID: 27389277
[TBL] [Abstract][Full Text] [Related]
2. Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells.
Wang W; Xie Q; Zhou X; Yao J; Zhu X; Huang P; Zhang L; Wei J; Xie H; Zhou L; Zheng S
Cancer Lett; 2015 Mar; 358(1):47-58. PubMed ID: 25541060
[TBL] [Abstract][Full Text] [Related]
3. Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells.
Wang W; Lu J; Zhu F; Wei J; Jia C; Zhang Y; Zhou L; Xie H; Zheng S
Med Oncol; 2012 Mar; 29(1):70-6. PubMed ID: 21190094
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells.
Wang W; Zhou D; Wei J; Wu Z; Cheng X; Sun Q; Xie H; Zhou L; Zheng S
Biochem Biophys Res Commun; 2012 May; 421(2):355-60. PubMed ID: 22510407
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
6. Mitofusin-2 Triggers Cervical Carcinoma Cell Hela Apoptosis via Mitochondrial Pathway in Mouse Model.
Wang W; Liu X; Guo X; Quan H
Cell Physiol Biochem; 2018; 46(1):69-81. PubMed ID: 29587277
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin-2.
Zhou X; Zhang L; Zheng B; Yan Y; Zhang Y; Xie H; Zhou L; Zheng S; Wang W
Cancer Sci; 2016 Apr; 107(4):424-32. PubMed ID: 26845057
[TBL] [Abstract][Full Text] [Related]
8. The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma.
Ma YY; Zhang GH; Li J; Wang SB; Hu ZM; Zhang CW; Li E
Hum Pathol; 2018 Dec; 82():273-281. PubMed ID: 30081150
[TBL] [Abstract][Full Text] [Related]
9. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
Hu X; He B; Zhou L; Xie H; Zheng S
Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
[TBL] [Abstract][Full Text] [Related]
10. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
12. High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients.
Cheng J; Qian D; Ding X; Song T; Cai M; Dan Xie ; Wang Y; Zhao J; Liu Z; Wu Z; Pang Q; Zhu L; Wang P; Hao X; Yuan Z
Cell Death Dis; 2018 Sep; 9(10):991. PubMed ID: 30250224
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
14. Effect of mitofusin 2 overexpression on the proliferation and apoptosis of high-glucose-induced rat glomerular mesangial cells.
Wan-Xin T; Tian-Lei C; Ben W; Wei-Hua W; Ping F
J Nephrol; 2012; 25(6):1023-30. PubMed ID: 22322822
[TBL] [Abstract][Full Text] [Related]
15. Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis.
Zhou H; Wang SC; Ma JM; Yu LQ; Jing JS
Med Sci Monit; 2018 Aug; 24():6021-6028. PubMed ID: 30157168
[TBL] [Abstract][Full Text] [Related]
16. MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.
Xu K; Chen G; Li X; Wu X; Chang Z; Xu J; Zhu Y; Yin P; Liang X; Dong L
Sci Rep; 2017 Feb; 7():41718. PubMed ID: 28176801
[TBL] [Abstract][Full Text] [Related]
17. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
[TBL] [Abstract][Full Text] [Related]
18. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
20. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
